Effect of Hyponatremia in Small Cell Lung Cancer

Completed

• Conditions: Small Cell Lung Cancer

• Registration Number: NCT04451460
• Lead Sponsor: Ankara City Hospital Bilkent

Brief Summary

In this retrospective study, the investigators determined the frequency of hyponatremia in small cell lung cancer and the prognosis. 126 (27%) of 466 patients were hyponatremic. Hyponatremia could not be corrected in 50.8% (n=64) of hyponatremic patients. Survival was found to be better in the group of whom hyponatremia was corrected.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01-01
• Primary Completion: 2017-01-01
• Study Completion: 2017-01-01
• Status Verified: 2020-06
• Study First Submitted: 2020-06-01
• Study First Submitted QC: 2020-06-25
• Last Update Submitted: 2020-06-25
• Study First Posted: 2020-06-30
• Last Update Posted: 2020-06-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 466

Inclusion Criteria

Patients diagnosed with SCLC between January 2012 and January 2017 in our hospital were retrospectively screened

Exclusion Criteria

Over 18 age If data doesn't exist

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality	Through study completion, an average of 3 months	Effect of hyponatremia according to mortality